Clinical Trials Browser

Completed × sintilimab × Tumor-Agnostic × Clear all

NCT05024968 2026-02-25

Sintilimab in Cancer of Unknown Primary

Phase 2 Completed

10 enrolled 9 charts

Neoplasms, Unknown Primary

NCT04055792 2023-06-28

Sintilimab Combined With Anlotinib as Second or Further-line Therapy for ED-SCLC

Phase 2 Completed

Neoplasm Metastasis

NCT02937116 2022-10-14

First in Human Study of IBI308 in Chinese Subjects With Advanced Solid Tumors

Phase 1 Completed

233 enrolled 30 charts

Neoplasms